Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. [electronic resource]
Producer: 20080528Description: 9986-98 p. digitalISSN:- 0021-9258
- Acetylcysteine -- pharmacology
- Adrenergic Agents -- toxicity
- Animals
- Apoptosis -- drug effects
- Caspase 3 -- metabolism
- Cell Line
- Disease Models, Animal
- Enzyme Activation -- drug effects
- Mesencephalon -- metabolism
- Neurons -- metabolism
- Oxidation-Reduction -- drug effects
- Oxidopamine -- toxicity
- Parkinson Disease, Secondary -- chemically induced
- Peroxiredoxins -- metabolism
- Rats
- Rats, Sprague-Dawley
- Reactive Oxygen Species -- metabolism
- Signal Transduction -- drug effects
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.